Davenport & Co’s Mustang Bio MBIO Stock Holding History

Davenport & Co’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40	Closed	-$11.1K	–	1073
2023 Q1	$11.1K	Hold	40	–	–	﹤0.01%	1035
2022 Q4	$12K	Sell	40 -7	-15%	-$2.39K	﹤0.01%	998
2022 Q3	$17K	Hold	47	–	–	﹤0.01%	984
2022 Q2	$21K	Sell	47 -4	-8%	-$2.21K	﹤0.01%	983
2022 Q1	$38K	Hold	51	–	–	﹤0.01%	1049
2021 Q4	$63K	Sell	51 -42	-45%	-$67.8K	﹤0.01%	1059
2021 Q3	$187K	Hold	93	–	–	﹤0.01%	984
2021 Q2	$232K	Hold	93	–	–	﹤0.01%	869
2021 Q1	$232K	Hold	93	–	–	﹤0.01%	726
2020 Q4	$265K	Buy	93 +6	+7%	+$14.3K	﹤0.01%	674
2020 Q3	$206K	Sell	87 -14	-14%	-$34.5K	﹤0.01%	675
2020 Q2	$240K	Hold	101	–	–	﹤0.01%	604
2020 Q1	$202K	Buy	+101	New	+$259K	﹤0.01%	586

Other funds holding MBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Davenport & Co's MBIO Position: Q2 2023 in Review

Davenport & Co sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 40 shares — an estimated $11.1K sold.

Davenport & Co first reported a position in MBIO in Q1 2020 and held it in 13 quarters. The position peaked at $265K in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

Davenport & Co reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
Davenport & Co sold 40 Mustang Bio shares in Q2 2023, an estimated $11.1K.
Davenport & Co first reported a position in Mustang Bio in Q1 2020 and held it in 13 quarters.
Davenport & Co's Mustang Bio position peaked at $265K in Q4 2020.
27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Davenport & Co's 13F filing for Q2 2023, filed 20 Jul 2023.